Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)
Phase 2
Terminated
- Conditions
- Out-Of-Hospital Cardiac ArrestPneumonia
- Interventions
- Drug: Standard of care without prophylaxisDrug: Antibiotic prophylaxis
- First Posted Date
- 2021-08-11
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- David J. Gagnon
- Target Recruit Count
- 53
- Registration Number
- NCT04999592
- Locations
- 🇺🇸
Maine Medical Center, Portland, Maine, United States
News
No news found